Aggregated China Media News & Blogs



SFDA Supervises Zelnorm In China

Aggregated Source: ChinaCSR.com
April 22, 2007|

Following Novartis' suspension of Zelnorm sales and marketing on the United States, the State Food and Drug Administration of China says that it will not force a recall, but instead keep a close watch on the safety of this prescriptive medication.

Original URL: Click here to visit original article
Copyright ChinaCSR.com
Print This Post Print This Post | Email To Friend

1 Stars2 Stars3 Stars4 Stars5 Stars6 Stars7 Stars8 Stars9 Stars10 Stars

30 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 1030 Votes | Average: 6.43 out of 10 (30 votes, average: 6.43 out of 10)


Related Info:
  • SFDA Exposes Fake Chinese Medicine Websites
  • SFDA Exposes Fake Chinese Medicine Websites
  • SFDA Wants Better Pharmaceutical Advertising
  • Illegal Drug Sales & A Touch of Cynicism
  • SFDA: Only Four Chinese Drug Retail Websites Are Legal

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |